  Aim: This study is looking for a common pathogenicity between SARS-CoV-2 and
plasmodium species, in individuals with certain HLA serotypes. Methods: 1-)
Tblastx searches of SARS-CoV-2 are performed by limiting searches to plasmodium
species that infect human. 2-) Aligned sequences in the respective organisms'
proteomes are searched with blastp. 3-) Binding predictions of the identified
SARS-CoV-2 peptide to MHC class I supertype representatives are performed. 4-)
Blastp searches of predicted-epitopes that bind strongly to the identified HLA
allele are performed by limiting searches to human and to the plasmodium
species. 5-) Peptides with minimum 60 % identity to the predicted-epitopes are
found in results. 6-) Peptides among those, which bind strongly to the same HLA
allele, are predicted. 7-) Step-4 is repeated by limiting searches to human,
for peptides sourced by limiting searches to plasmodium species at step-4. 8-)
Step-5 and 6 are performed with results of 7. Results: CFLGYFCTCYFGLFC peptide
of SARS-CoV-2 has the highest identity to P. vivax. Its GYFCTCYFGLF and
YFCTCYFGLF parts are predicted to bind strongly to HLA-A*24:02. Results
obtained only for peptides homologous to YFCTCYFGLF, as follows: YYCARRFGLF,
YYCHCPFGVF, and YYCQQYFFLF are potential HLA-A*24:02 epitopes in the human
proteome. Among FFYTFYFELF, YFVACLFILF, and YFPTITFHLF peptides in the
plasmodium species' proteomes with strong binding affinity to HLA-A*24:02, only
FFYTFYFELF of P. falciparum is homologous to the potential HLA-A*24:02 epitope
YFYLFSLELF in the human proteome. Conclusion: Immune responses to the
identified-peptides with similar sequences and strong binding affinities to
HLA-A*24:02 may lead to autoimmune response risk in individuals with
HLA-A*24:02 serotypes, upon getting infected with SARS-CoV-2 or P. falciparum.
